CU06-1004
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for CU06-1004, covering 2024-05-03 to 2026-03-10. Get the full timeline:
Most recent: Clinical Trial Update: Study of CU06-1004 in Patients With Daibetic Macular Edema [Phase 2]